Concepts (363)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Porifera | 7 | 2025 | 15 | 3.010 |
Why?
|
| Ventral Tegmental Area | 6 | 2021 | 47 | 2.930 |
Why?
|
| Cocaine | 8 | 2021 | 248 | 2.820 |
Why?
|
| Kidney Transplantation | 9 | 2023 | 102 | 2.490 |
Why?
|
| Potassium Channels | 2 | 2019 | 81 | 0.940 |
Why?
|
| Mycophenolic Acid | 3 | 2023 | 17 | 0.940 |
Why?
|
| Sesterterpenes | 1 | 2024 | 1 | 0.910 |
Why?
|
| Adenoviruses, Human | 1 | 2024 | 4 | 0.900 |
Why?
|
| Nephrology | 1 | 2023 | 19 | 0.830 |
Why?
|
| Tetraodontiformes | 1 | 2023 | 4 | 0.820 |
Why?
|
| Siderophores | 5 | 2025 | 14 | 0.780 |
Why?
|
| Antiviral Agents | 1 | 2024 | 189 | 0.770 |
Why?
|
| Animals | 29 | 2025 | 16695 | 0.760 |
Why?
|
| Agelas | 1 | 2022 | 1 | 0.760 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2023 | 230 | 0.730 |
Why?
|
| Phenazines | 1 | 2021 | 6 | 0.710 |
Why?
|
| Anti-Infective Agents | 1 | 2022 | 74 | 0.710 |
Why?
|
| Photochemical Processes | 1 | 2021 | 19 | 0.710 |
Why?
|
| Actinobacteria | 1 | 2021 | 14 | 0.700 |
Why?
|
| Geologic Sediments | 1 | 2021 | 47 | 0.700 |
Why?
|
| Diterpenes | 2 | 2019 | 94 | 0.690 |
Why?
|
| Anti-Bacterial Agents | 3 | 2022 | 415 | 0.680 |
Why?
|
| Urochordata | 1 | 2020 | 4 | 0.670 |
Why?
|
| Molecular Structure | 8 | 2025 | 560 | 0.660 |
Why?
|
| Protein Kinase C | 2 | 2018 | 124 | 0.650 |
Why?
|
| Rats, Sprague-Dawley | 10 | 2019 | 1737 | 0.630 |
Why?
|
| Marine Toxins | 1 | 2019 | 17 | 0.620 |
Why?
|
| Liver Transplantation | 4 | 2021 | 37 | 0.620 |
Why?
|
| Nitrogen | 3 | 2015 | 83 | 0.600 |
Why?
|
| Limbic System | 1 | 2019 | 31 | 0.590 |
Why?
|
| Receptors, AMPA | 1 | 2018 | 57 | 0.580 |
Why?
|
| Long-Term Potentiation | 1 | 2018 | 109 | 0.560 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2018 | 133 | 0.550 |
Why?
|
| Nucleus Accumbens | 1 | 2018 | 99 | 0.550 |
Why?
|
| Mexico | 5 | 2022 | 286 | 0.540 |
Why?
|
| Bacteria | 1 | 2020 | 285 | 0.530 |
Why?
|
| Cerebral Cortex | 1 | 2019 | 303 | 0.520 |
Why?
|
| Acclimatization | 2 | 2014 | 25 | 0.500 |
Why?
|
| Excitatory Postsynaptic Potentials | 2 | 2016 | 80 | 0.500 |
Why?
|
| Tissue Donors | 4 | 2021 | 55 | 0.480 |
Why?
|
| Structure-Activity Relationship | 4 | 2024 | 491 | 0.480 |
Why?
|
| Rats | 9 | 2021 | 3701 | 0.480 |
Why?
|
| Immunosuppressive Agents | 5 | 2023 | 94 | 0.480 |
Why?
|
| Colchicine | 1 | 2015 | 15 | 0.470 |
Why?
|
| Neural Inhibition | 2 | 2012 | 48 | 0.460 |
Why?
|
| Stilbenes | 1 | 2015 | 44 | 0.450 |
Why?
|
| Receptors, Adrenergic, alpha-1 | 1 | 2014 | 13 | 0.450 |
Why?
|
| Tubulin | 1 | 2015 | 94 | 0.450 |
Why?
|
| Photosynthesis | 1 | 2014 | 34 | 0.440 |
Why?
|
| Carbon Dioxide | 1 | 2014 | 86 | 0.430 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2014 | 81 | 0.430 |
Why?
|
| Gene Expression | 2 | 2019 | 692 | 0.430 |
Why?
|
| Motor Activity | 4 | 2016 | 438 | 0.430 |
Why?
|
| Graft Survival | 5 | 2022 | 47 | 0.420 |
Why?
|
| Male | 18 | 2023 | 22779 | 0.420 |
Why?
|
| Magnetic Resonance Spectroscopy | 5 | 2021 | 300 | 0.400 |
Why?
|
| Ion Channels | 1 | 2012 | 74 | 0.390 |
Why?
|
| Cyclic Nucleotide-Gated Cation Channels | 1 | 2012 | 5 | 0.370 |
Why?
|
| Anthozoa | 2 | 2010 | 24 | 0.370 |
Why?
|
| Receptors, Adrenergic, alpha-2 | 1 | 2012 | 39 | 0.370 |
Why?
|
| Cell Size | 1 | 2012 | 46 | 0.370 |
Why?
|
| Antineoplastic Agents | 2 | 2021 | 979 | 0.360 |
Why?
|
| Microbial Sensitivity Tests | 3 | 2022 | 232 | 0.360 |
Why?
|
| Bivalvia | 2 | 2021 | 25 | 0.350 |
Why?
|
| Vibrio | 2 | 2021 | 18 | 0.350 |
Why?
|
| Glutamic Acid | 1 | 2012 | 131 | 0.350 |
Why?
|
| Neuroblastoma | 2 | 2022 | 134 | 0.350 |
Why?
|
| Ascomycota | 2 | 2025 | 21 | 0.350 |
Why?
|
| Behavior, Animal | 3 | 2018 | 369 | 0.340 |
Why?
|
| Humans | 28 | 2024 | 42163 | 0.320 |
Why?
|
| Tissue and Organ Procurement | 2 | 2021 | 56 | 0.310 |
Why?
|
| Drug Screening Assays, Antitumor | 4 | 2019 | 147 | 0.310 |
Why?
|
| Shock | 2 | 2019 | 7 | 0.310 |
Why?
|
| Tetrodotoxin | 2 | 2023 | 23 | 0.300 |
Why?
|
| Pyrrolidines | 1 | 2008 | 30 | 0.290 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 81 | 0.290 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 86 | 0.290 |
Why?
|
| Heart Arrest | 2 | 2018 | 52 | 0.290 |
Why?
|
| Tacrolimus | 3 | 2023 | 15 | 0.290 |
Why?
|
| Retrospective Studies | 4 | 2023 | 2485 | 0.280 |
Why?
|
| Organ Preservation | 4 | 2021 | 5 | 0.270 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 2006 | 29 | 0.250 |
Why?
|
| Eukaryota | 1 | 2006 | 20 | 0.250 |
Why?
|
| Phosphates | 1 | 2006 | 54 | 0.250 |
Why?
|
| Brain | 2 | 2012 | 1452 | 0.250 |
Why?
|
| Spain | 6 | 2023 | 43 | 0.250 |
Why?
|
| Nitrates | 1 | 2006 | 63 | 0.240 |
Why?
|
| Seasons | 1 | 2006 | 133 | 0.240 |
Why?
|
| Chromatography, Liquid | 2 | 2025 | 173 | 0.240 |
Why?
|
| Penicillium | 1 | 2025 | 7 | 0.240 |
Why?
|
| Cheese | 1 | 2025 | 4 | 0.240 |
Why?
|
| Perfusion | 3 | 2021 | 39 | 0.240 |
Why?
|
| Electric Stimulation | 2 | 2016 | 198 | 0.230 |
Why?
|
| Lactams | 1 | 2024 | 9 | 0.230 |
Why?
|
| Cell Line, Tumor | 5 | 2021 | 2598 | 0.220 |
Why?
|
| Antilymphocyte Serum | 1 | 2023 | 4 | 0.210 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2017 | 1112 | 0.210 |
Why?
|
| Prednisone | 1 | 2023 | 31 | 0.210 |
Why?
|
| El Salvador | 1 | 2023 | 3 | 0.210 |
Why?
|
| Waste Disposal, Fluid | 3 | 2008 | 19 | 0.200 |
Why?
|
| Enzyme Inhibitors | 2 | 2018 | 457 | 0.200 |
Why?
|
| Spectrophotometry | 2 | 2021 | 63 | 0.200 |
Why?
|
| Organ Transplantation | 1 | 2023 | 26 | 0.200 |
Why?
|
| Patch-Clamp Techniques | 2 | 2014 | 228 | 0.200 |
Why?
|
| Distemper Virus, Canine | 1 | 2022 | 1 | 0.200 |
Why?
|
| Communicable Diseases, Emerging | 1 | 2022 | 14 | 0.190 |
Why?
|
| Microsatellite Repeats | 1 | 2022 | 60 | 0.190 |
Why?
|
| alpha-Amylases | 2 | 2021 | 7 | 0.190 |
Why?
|
| RNA, Viral | 1 | 2023 | 317 | 0.180 |
Why?
|
| Genetics, Population | 1 | 2022 | 118 | 0.180 |
Why?
|
| Prazosin | 2 | 2014 | 9 | 0.180 |
Why?
|
| Passiflora | 1 | 2021 | 1 | 0.180 |
Why?
|
| Tablets, Enteric-Coated | 1 | 2021 | 2 | 0.180 |
Why?
|
| Electrophysiology | 1 | 2021 | 138 | 0.180 |
Why?
|
| Saponins | 1 | 2021 | 7 | 0.180 |
Why?
|
| Kidney | 2 | 2022 | 363 | 0.170 |
Why?
|
| Triterpenes | 1 | 2021 | 18 | 0.170 |
Why?
|
| Hydrogen-Ion Concentration | 5 | 2014 | 385 | 0.170 |
Why?
|
| Pulmonary Medicine | 1 | 2020 | 4 | 0.170 |
Why?
|
| Wetlands | 1 | 2020 | 15 | 0.170 |
Why?
|
| Light | 1 | 2021 | 182 | 0.160 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2020 | 34 | 0.160 |
Why?
|
| Time Factors | 3 | 2018 | 1848 | 0.160 |
Why?
|
| Immunocompromised Host | 1 | 2020 | 26 | 0.160 |
Why?
|
| Regression Analysis | 1 | 2021 | 487 | 0.160 |
Why?
|
| Carbon | 2 | 2014 | 127 | 0.160 |
Why?
|
| Kidney Failure, Chronic | 1 | 2022 | 239 | 0.160 |
Why?
|
| Action Potentials | 1 | 2021 | 246 | 0.160 |
Why?
|
| Donor Selection | 1 | 2019 | 10 | 0.160 |
Why?
|
| Clonidine | 2 | 2012 | 52 | 0.160 |
Why?
|
| Neuroprotective Agents | 1 | 2022 | 267 | 0.150 |
Why?
|
| Caribbean Region | 1 | 2019 | 75 | 0.150 |
Why?
|
| Female | 10 | 2023 | 24018 | 0.150 |
Why?
|
| Cell Survival | 2 | 2019 | 934 | 0.150 |
Why?
|
| Random Allocation | 1 | 2019 | 145 | 0.150 |
Why?
|
| Protein Subunits | 1 | 2019 | 93 | 0.150 |
Why?
|
| Plant Exudates | 1 | 2018 | 1 | 0.140 |
Why?
|
| Physalis | 1 | 2018 | 3 | 0.140 |
Why?
|
| Esters | 1 | 2018 | 25 | 0.140 |
Why?
|
| Postoperative Complications | 2 | 2018 | 253 | 0.140 |
Why?
|
| Patient Education as Topic | 1 | 2020 | 234 | 0.140 |
Why?
|
| Sucrose | 1 | 2018 | 33 | 0.140 |
Why?
|
| Impulsive Behavior | 1 | 2018 | 54 | 0.140 |
Why?
|
| Middle Aged | 6 | 2023 | 11819 | 0.140 |
Why?
|
| Withanolides | 1 | 2017 | 10 | 0.140 |
Why?
|
| Biophysics | 1 | 2016 | 38 | 0.130 |
Why?
|
| Lichens | 1 | 2016 | 2 | 0.130 |
Why?
|
| Iron | 2 | 2025 | 247 | 0.130 |
Why?
|
| Spinal Fractures | 1 | 2016 | 4 | 0.130 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2016 | 88 | 0.130 |
Why?
|
| Fruit | 1 | 2018 | 178 | 0.130 |
Why?
|
| Membrane Lipids | 1 | 2016 | 29 | 0.120 |
Why?
|
| Death | 3 | 2021 | 11 | 0.120 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2016 | 81 | 0.120 |
Why?
|
| Aortic Diseases | 1 | 2016 | 34 | 0.120 |
Why?
|
| Minerals | 1 | 2016 | 52 | 0.120 |
Why?
|
| Drug Design | 1 | 2017 | 183 | 0.120 |
Why?
|
| Phospholipase D | 1 | 2016 | 50 | 0.120 |
Why?
|
| Bacterial Proteins | 1 | 2020 | 580 | 0.120 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2017 | 134 | 0.120 |
Why?
|
| Calcinosis | 1 | 2016 | 61 | 0.120 |
Why?
|
| Phenyl Ethers | 1 | 2015 | 4 | 0.120 |
Why?
|
| Pregnancy | 1 | 2021 | 1737 | 0.120 |
Why?
|
| Ovarian Neoplasms | 1 | 2019 | 406 | 0.110 |
Why?
|
| Miniature Postsynaptic Potentials | 1 | 2014 | 4 | 0.110 |
Why?
|
| Nitro Compounds | 1 | 2015 | 34 | 0.110 |
Why?
|
| Adrenergic Agents | 1 | 2014 | 8 | 0.110 |
Why?
|
| Oceans and Seas | 1 | 2014 | 17 | 0.110 |
Why?
|
| Benzophenanthridines | 1 | 2014 | 11 | 0.110 |
Why?
|
| Inhibitory Postsynaptic Potentials | 1 | 2014 | 12 | 0.110 |
Why?
|
| Phenylephrine | 1 | 2014 | 32 | 0.110 |
Why?
|
| Tissue Culture Techniques | 1 | 2014 | 36 | 0.110 |
Why?
|
| Potassium Channel Blockers | 1 | 2014 | 34 | 0.110 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channels | 1 | 2014 | 19 | 0.110 |
Why?
|
| MAP Kinase Signaling System | 1 | 2016 | 189 | 0.110 |
Why?
|
| Electron Transport | 1 | 2014 | 45 | 0.110 |
Why?
|
| Presynaptic Terminals | 1 | 2014 | 54 | 0.110 |
Why?
|
| Particle Size | 1 | 2015 | 267 | 0.110 |
Why?
|
| Ultraviolet Rays | 1 | 2014 | 118 | 0.110 |
Why?
|
| Models, Molecular | 2 | 2015 | 875 | 0.110 |
Why?
|
| Species Specificity | 1 | 2014 | 279 | 0.110 |
Why?
|
| Cell Cycle | 1 | 2015 | 348 | 0.100 |
Why?
|
| Binding Sites | 1 | 2015 | 670 | 0.100 |
Why?
|
| MicroRNAs | 1 | 2019 | 501 | 0.100 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2014 | 159 | 0.100 |
Why?
|
| Ecosystem | 1 | 2014 | 171 | 0.100 |
Why?
|
| Indoles | 1 | 2014 | 178 | 0.100 |
Why?
|
| Multigene Family | 2 | 2025 | 105 | 0.100 |
Why?
|
| Cell Proliferation | 2 | 2017 | 1420 | 0.100 |
Why?
|
| alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 2012 | 10 | 0.100 |
Why?
|
| Sex Factors | 1 | 2016 | 1008 | 0.100 |
Why?
|
| Excitatory Amino Acids | 1 | 2012 | 7 | 0.100 |
Why?
|
| Quinoxalines | 1 | 2012 | 17 | 0.100 |
Why?
|
| Protein Isoforms | 1 | 2012 | 139 | 0.090 |
Why?
|
| Sodium Channel Blockers | 1 | 2012 | 18 | 0.090 |
Why?
|
| Students | 1 | 2018 | 617 | 0.090 |
Why?
|
| Locomotion | 1 | 2012 | 104 | 0.090 |
Why?
|
| Listonella | 1 | 2011 | 1 | 0.090 |
Why?
|
| Antarctic Regions | 2 | 2025 | 10 | 0.090 |
Why?
|
| Depression | 1 | 2018 | 837 | 0.090 |
Why?
|
| Mass Spectrometry | 2 | 2025 | 279 | 0.080 |
Why?
|
| Emulsions | 2 | 2008 | 35 | 0.080 |
Why?
|
| Graft Rejection | 2 | 2022 | 43 | 0.080 |
Why?
|
| Aluminum Compounds | 2 | 2007 | 10 | 0.080 |
Why?
|
| Cell Death | 2 | 2008 | 277 | 0.080 |
Why?
|
| Intestinal Fistula | 1 | 2010 | 4 | 0.080 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2010 | 14 | 0.080 |
Why?
|
| Mice | 3 | 2021 | 6490 | 0.080 |
Why?
|
| Anti-HIV Agents | 1 | 2014 | 475 | 0.080 |
Why?
|
| Immunologic Factors | 1 | 2010 | 50 | 0.080 |
Why?
|
| Cyclosporine | 2 | 2022 | 36 | 0.080 |
Why?
|
| Apoptosis | 1 | 2017 | 1541 | 0.080 |
Why?
|
| Aged | 5 | 2021 | 7982 | 0.080 |
Why?
|
| Crohn Disease | 1 | 2010 | 69 | 0.080 |
Why?
|
| Comorbidity | 2 | 2023 | 725 | 0.080 |
Why?
|
| Plant Leaves | 2 | 2021 | 134 | 0.070 |
Why?
|
| Biological Assay | 1 | 2008 | 63 | 0.070 |
Why?
|
| Environmental Monitoring | 1 | 2010 | 226 | 0.070 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2008 | 15 | 0.070 |
Why?
|
| Peptides | 1 | 2011 | 357 | 0.070 |
Why?
|
| Costa Rica | 2 | 2022 | 9 | 0.070 |
Why?
|
| Chemistry, Organic | 1 | 2007 | 6 | 0.070 |
Why?
|
| Steroids | 1 | 2007 | 45 | 0.070 |
Why?
|
| Risk Factors | 3 | 2021 | 3942 | 0.060 |
Why?
|
| Idazoxan | 1 | 2006 | 10 | 0.060 |
Why?
|
| Nitrate Reductase | 1 | 2006 | 2 | 0.060 |
Why?
|
| Atlantic Ocean | 1 | 2006 | 2 | 0.060 |
Why?
|
| Yohimbine | 1 | 2006 | 26 | 0.060 |
Why?
|
| Carbonic Anhydrases | 1 | 2006 | 8 | 0.060 |
Why?
|
| Coloring Agents | 1 | 2006 | 56 | 0.060 |
Why?
|
| Arctic Regions | 1 | 2006 | 21 | 0.060 |
Why?
|
| Chlorophyll | 1 | 2006 | 24 | 0.060 |
Why?
|
| Alkaline Phosphatase | 1 | 2006 | 53 | 0.060 |
Why?
|
| Endothelium, Vascular | 1 | 2008 | 261 | 0.060 |
Why?
|
| Age Factors | 2 | 2019 | 1139 | 0.060 |
Why?
|
| Acetylation | 1 | 2025 | 108 | 0.060 |
Why?
|
| Endothelial Cells | 1 | 2008 | 324 | 0.060 |
Why?
|
| Treatment Outcome | 2 | 2019 | 1586 | 0.050 |
Why?
|
| Water Pollutants, Chemical | 1 | 2006 | 170 | 0.050 |
Why?
|
| Communicable Disease Control | 1 | 2023 | 38 | 0.050 |
Why?
|
| Animals, Wild | 1 | 2022 | 24 | 0.050 |
Why?
|
| Cyclophilins | 1 | 2022 | 10 | 0.050 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2002 | 18 | 0.050 |
Why?
|
| Cyclophilin A | 1 | 2022 | 19 | 0.050 |
Why?
|
| Narcotics | 1 | 2002 | 30 | 0.050 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2022 | 51 | 0.050 |
Why?
|
| Living Donors | 1 | 2022 | 18 | 0.050 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2022 | 34 | 0.050 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2002 | 55 | 0.050 |
Why?
|
| Vaccines, Synthetic | 1 | 2022 | 78 | 0.050 |
Why?
|
| Drug Therapy, Combination | 1 | 2022 | 233 | 0.050 |
Why?
|
| Gene Frequency | 1 | 2022 | 203 | 0.050 |
Why?
|
| Disease Outbreaks | 1 | 2022 | 169 | 0.040 |
Why?
|
| Testosterone | 1 | 2002 | 211 | 0.040 |
Why?
|
| Virulence | 1 | 2021 | 238 | 0.040 |
Why?
|
| Estrogens | 1 | 2002 | 202 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2021 | 256 | 0.040 |
Why?
|
| Seawater | 1 | 2020 | 53 | 0.040 |
Why?
|
| Metabolomics | 1 | 2021 | 90 | 0.040 |
Why?
|
| Emergencies | 1 | 2020 | 32 | 0.040 |
Why?
|
| Dyspnea | 1 | 2020 | 23 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2002 | 253 | 0.040 |
Why?
|
| Respiration, Artificial | 1 | 2020 | 47 | 0.040 |
Why?
|
| Intensive Care Units | 1 | 2020 | 71 | 0.040 |
Why?
|
| Genome, Bacterial | 1 | 2020 | 132 | 0.040 |
Why?
|
| Vaccination | 1 | 2022 | 332 | 0.040 |
Why?
|
| Wnt1 Protein | 1 | 2019 | 2 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2017 | 1617 | 0.040 |
Why?
|
| Medical Futility | 1 | 2019 | 10 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2021 | 1554 | 0.040 |
Why?
|
| Delayed Graft Function | 1 | 2018 | 2 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2019 | 62 | 0.040 |
Why?
|
| Cold Ischemia | 1 | 2018 | 3 | 0.040 |
Why?
|
| Cadaver | 1 | 2018 | 40 | 0.040 |
Why?
|
| Cell Adhesion Molecules | 1 | 2019 | 84 | 0.040 |
Why?
|
| Propensity Score | 1 | 2018 | 58 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2018 | 3077 | 0.040 |
Why?
|
| Antigens, Neoplasm | 1 | 2019 | 77 | 0.040 |
Why?
|
| Survival Rate | 1 | 2019 | 353 | 0.040 |
Why?
|
| Glomerular Filtration Rate | 1 | 2018 | 144 | 0.040 |
Why?
|
| Likelihood Functions | 1 | 2018 | 62 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2019 | 403 | 0.040 |
Why?
|
| Kinetics | 2 | 2011 | 698 | 0.030 |
Why?
|
| Cause of Death | 1 | 2018 | 183 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2019 | 158 | 0.030 |
Why?
|
| Withania | 1 | 2017 | 6 | 0.030 |
Why?
|
| Plant Extracts | 1 | 2021 | 303 | 0.030 |
Why?
|
| Young Adult | 2 | 2018 | 4936 | 0.030 |
Why?
|
| Vero Cells | 1 | 2017 | 109 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2019 | 452 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2022 | 1265 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2019 | 297 | 0.030 |
Why?
|
| Adolescent | 2 | 2018 | 5950 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2018 | 280 | 0.030 |
Why?
|
| Registries | 1 | 2019 | 431 | 0.030 |
Why?
|
| Self Concept | 1 | 2018 | 170 | 0.030 |
Why?
|
| Hyperparathyroidism, Secondary | 1 | 2016 | 13 | 0.030 |
Why?
|
| Osmotic Pressure | 1 | 2016 | 22 | 0.030 |
Why?
|
| Dehydration | 1 | 2016 | 23 | 0.030 |
Why?
|
| Aorta, Abdominal | 1 | 2016 | 17 | 0.030 |
Why?
|
| Parathyroid Hormone | 1 | 2016 | 40 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 1051 | 0.030 |
Why?
|
| Adult | 3 | 2018 | 13458 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2019 | 557 | 0.030 |
Why?
|
| Albuminuria | 1 | 2016 | 78 | 0.030 |
Why?
|
| Mutation | 1 | 2020 | 1169 | 0.030 |
Why?
|
| Adaptation, Physiological | 1 | 2016 | 135 | 0.030 |
Why?
|
| Logistic Models | 1 | 2018 | 1001 | 0.030 |
Why?
|
| Neurons | 1 | 2002 | 1246 | 0.030 |
Why?
|
| Vitamin D Deficiency | 1 | 2016 | 107 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2016 | 201 | 0.030 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2015 | 84 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2019 | 722 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2018 | 1516 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2019 | 933 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2016 | 973 | 0.030 |
Why?
|
| Antifungal Agents | 1 | 2015 | 169 | 0.030 |
Why?
|
| Prevalence | 1 | 2018 | 1597 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 2803 | 0.020 |
Why?
|
| Potentiometry | 1 | 2011 | 8 | 0.020 |
Why?
|
| Fish Diseases | 1 | 2011 | 8 | 0.020 |
Why?
|
| Organometallic Compounds | 1 | 2011 | 72 | 0.020 |
Why?
|
| Ferric Compounds | 1 | 2011 | 62 | 0.020 |
Why?
|
| Pacific Ocean | 1 | 2010 | 13 | 0.020 |
Why?
|
| Child | 1 | 2018 | 3381 | 0.020 |
Why?
|
| Population Density | 1 | 2010 | 32 | 0.020 |
Why?
|
| Models, Chemical | 1 | 2011 | 205 | 0.020 |
Why?
|
| Oils | 1 | 2008 | 6 | 0.020 |
Why?
|
| HIV-1 | 1 | 2014 | 747 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2010 | 522 | 0.020 |
Why?
|
| Aluminum | 1 | 2008 | 39 | 0.020 |
Why?
|
| Uridine Triphosphate | 1 | 2008 | 7 | 0.020 |
Why?
|
| Fura-2 | 1 | 2008 | 13 | 0.020 |
Why?
|
| Umbilical Veins | 1 | 2008 | 18 | 0.020 |
Why?
|
| Adenosine Diphosphate | 1 | 2008 | 21 | 0.020 |
Why?
|
| Retinal Vessels | 1 | 2008 | 29 | 0.020 |
Why?
|
| Algorithms | 1 | 2011 | 508 | 0.020 |
Why?
|
| Electrochemistry | 1 | 2007 | 38 | 0.020 |
Why?
|
| Hydrolysis | 1 | 2007 | 98 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2010 | 733 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2008 | 151 | 0.020 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2008 | 184 | 0.020 |
Why?
|
| Dimerization | 1 | 2007 | 115 | 0.020 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2007 | 98 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2008 | 205 | 0.020 |
Why?
|
| Industrial Waste | 1 | 2006 | 16 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2008 | 182 | 0.020 |
Why?
|
| Cattle | 1 | 2008 | 505 | 0.020 |
Why?
|
| Water | 1 | 2008 | 314 | 0.020 |
Why?
|
| Temperature | 1 | 2006 | 314 | 0.010 |
Why?
|
| Calcium | 1 | 2008 | 487 | 0.010 |
Why?
|
| Muscarinic Agonists | 1 | 2002 | 10 | 0.010 |
Why?
|
| Pilocarpine | 1 | 2002 | 8 | 0.010 |
Why?
|
| Kainic Acid | 1 | 2002 | 48 | 0.010 |
Why?
|
| Stereotyped Behavior | 1 | 2002 | 23 | 0.010 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2002 | 45 | 0.010 |
Why?
|
| Naloxone | 1 | 2002 | 56 | 0.010 |
Why?
|
| Corticosterone | 1 | 2002 | 89 | 0.010 |
Why?
|
| Ovariectomy | 1 | 2002 | 128 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2002 | 151 | 0.010 |
Why?
|
| Reaction Time | 1 | 2002 | 151 | 0.010 |
Why?
|
| Estradiol | 1 | 2002 | 269 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2002 | 727 | 0.010 |
Why?
|